Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A
KNSA
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.72B
Close$
$68.17
15.8% downsideKiniksa Pharmaceuticals International Plc. Target Price Details
Target Price by Analysts
15.8% downsideKiniksa Pharmaceuticals International Plc. Target Price Details$-4.53105.6% downside
Current Fair Value
105.6% downsideOvervalued by 105.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.72 Billion |
|---|---|
| Enterprise Value | $4.54 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.8 |
| Beta | 0.07 |
| Outstanding Shares | 76,516,535 |
Return
| Return on Equity | 12.06% |
|---|---|
| Return on Assets | 8.85% |
| Return on Invested Capital | 14.52% |
Valuation & Multiples
| P/E Ratio | 64.12 |
|---|---|
| PEG | 38.96 |
| Price to Sales | 8.99 |
| Price to Book Ratio | 11.56 |
| Enterprise Value to Revenue | 6.02 |
| Enterprise Value to EBIT | 46.8 |
| Enterprise Value to Net Income | 62 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 28, 2026
EPS Estimate
$0.30
Average shareholder expectationRevenue Estimate
$226.49 M
Average shareholder expectationNext Earnings Call
Expected Date
August 4, 2026
EPS Estimate
$0.24
Average shareholder expectationRevenue Estimate
$226.33 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 2.20% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.56%▼ 60.63% |
|---|---|
| Total Invested | $27.23M▼ 98.75% |
| Investors Holding | 35▼ 199.00% |
ESG Score
No data